Who
Arnold M. Baskies
Director
Company insider
Files Form 4 as: Director, Anixa Biosciences; Director, Baudax Bio.
In numbers
- Trades disclosed
- 47
- Buys
- 15
- Sells
- 0
- Bought
- $550K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Jan 2017
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.76 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.76 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code M | $19K6,000 at $3.13 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code F | $19K5,428 at $3.46 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code M | $19K6,000 at $3.13 | filing |
| 27 Jul 2026filed 29 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Code F | $19K5,428 at $3.46 | filing |
| 28 Jan 2026filed 29 Jan 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $30K10,000 at $3.04 | filing |
| 28 Jan 2026filed 29 Jan 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $30K10,000 at $3.04 | filing |
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 18 Jul 2025filed 21 Jul 2025 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.39 | filing |
| 28 Jan 2025filed 29 Jan 2025 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.82 | filing |
| 2 Jan 2025filed 3 Jan 2025 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 26 Jul 2024filed 26 Jul 2024 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $15K5,000 at $3.09 | filing |
| 15 Mar 2024filed 15 Mar 2024 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $36K10,000 at $3.63 | filing |
| 12 Jan 2024filed 16 Jan 2024 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | Baudax Bio | SEC FORM 4 Code A | —39,473 at $0.00 | filing |
News
Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonANIX · dailypolitical.com · 16 Oct 2026Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer VaccineANIX · hawaiitelegraph.com · 13 Oct 2026
0 headlines in the last 90 days name Arnold M. Baskies; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.